Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Cogent Biosciences (COGT) EBIT Margin (2017 - 2020)

Cogent Biosciences (COGT) has 3 years of EBIT Margin data on record, last reported at 18333.01% in Q3 2020.

  • For Q3 2020, EBIT Margin fell 1715301.0% year-over-year to 18333.01%; the TTM value through Jun 2021 reached 31649.68%, down 3155189.0%, while the annual FY2025 figure was 10887.1%, N/A changed from the prior year.
  • EBIT Margin reached 18333.01% in Q3 2020 per COGT's latest filing, down from 1402.08% in the prior quarter.
  • Across five years, EBIT Margin topped out at 14.65% in Q4 2019 and bottomed at 18333.01% in Q3 2020.
  • Average EBIT Margin over 3 years is 2122.46%, with a median of 387.85% recorded in 2019.
  • The widest YoY moves for EBIT Margin: up 30051bps in 2020, down -1715301bps in 2020.
  • A 3-year view of EBIT Margin shows it stood at 236.64% in 2018, then skyrocketed by 106bps to 14.65% in 2019, then crashed by -125223bps to 18333.01% in 2020.
  • Per Business Quant database, its latest 3 readings for EBIT Margin were 18333.01% in Q3 2020, 1402.08% in Q2 2020, and 87.34% in Q1 2020.